Skip to content
TrialScanner

NCT05995444

A Study to Assess the Effects of Epetraborole on the QT Interval in Healthy Adult Subjects

Phase 1CompletedANTXLead

Registry record

Lead sponsor
AN2 Therapeutics, Inc
Conditions
Healthy Volunteers
Primary completion
Jul 26, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05995444 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05995444: A Study to Assess the... | TrialScanner